The effect of prophylactic dose of a low molecular weight heparin on skin wound healing of rats

Acta Cirurgica Brasileira

Volumn 24, Issue 6, 2009, Pages 471-475

  Oken, Ozdamar Fuad ^a   Yildirim, Ahmet Ozgur ^a   Gulcek, Murat ^a   Una, Vuslat Sema ^a   Karakuyu, Akin ^a   Ozlu, Korhan ^a   Ucaner, Ahmet ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Heparin, low molecular weight; Rats; Wound healing

Indexed keywords

ENOXAPARIN; ANTICOAGULANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPITHELIZATION; FIBROSIS; HISTOPATHOLOGY; INFLAMMATION; NONHUMAN; PROPHYLAXIS; RAT; SKIN INJURY; TENSILE STRENGTH; VASCULARIZATION; WOUND HEALING; ANIMAL; ANIMAL MODEL; DRUG EFFECTS; FIBROBLAST; INBRED RAT STRAIN; NONPARAMETRIC TEST; PATHOLOGY; RANDOMIZATION; SKIN; VENOUS THROMBOSIS; WISTAR RAT;

ANIMALS; ANTICOAGULANTS; ENOXAPARIN; FIBROBLASTS; MODELS, ANIMAL; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; RATS, WISTAR; SKIN; STATISTICS, NONPARAMETRIC; TENSILE STRENGTH; VENOUS THROMBOSIS; WOUND HEALING;

EID: 74249122580     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502009000600009     Document Type: Article

References (23)

1. Street JT, McGrath M, O' Regan K, Wakai A, McGuinness A, Redmond HP. Thromboprophylaxis using a low molecular weight heparin delays fracture repair. Clin Orthop Relat Res. 2000;(381):278-89.
2. Matzsch T, Bergqvist D, Blomquist P, Jiborn H. ?nfluence of standard heparin or low molecular weight heparin on healing of abdominal wounds and colonic anastomoses in rats. Acta Chir Scand. 1987;153(10):593-8.
3. Weitz JI. Low molecular weight heparins. N Engl J Med. 1997;337(10):688-98.
4. Wysocki AB. Wound measurement. Int J Dermatol. 1996;35(2):82-91.
5. Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg. 1973;177(2):222-7.
6. Loewen MS, Walner DL, Caldarelli DD. Improved airway healing using transforming growth factor beta-3 in a rabbit model. Wound Repair Regen. 2001;9(1):44-9.
7. Schaffer CJ, Nanney LB. Cell biology of wound healing. Int Rev Cytol. 1996;169:151-81.
8. Andereya S, Kalicke T, Hopf KF, Buschmeier M, Muhr G. Serious complication after subcutaneous injection of heparin for prophylaxis of thromboembolism. Unfallchirurg. 2003;106(2):182-3
9. Burns JL, Mancoll JS, Phillips LG. Impairments to wound healing. Clin Plast Surg. 2003;30:47-56.
10. Salvati EA, Lachiewicz P. Thromboembolism following total hip-replacement arthroplasty. The efficacy of dextran-aspirin and dextran-warfarin in prophylaxis. J Bone Joint Surg Am. 1976;58:921-5.
11. Lemke H, Imhoff M, Lohlein D. Increased wound healing disorders in patients with inguinal hernia caused by administration of antithrombotic agents in the abdominal wall. Chirurg. 1994; 65(8):714-6.
12. Seveljevic-Jaran D. Wound healing: methods and protocols. Inflamm Res. 2003;52(11):441-2.
13. Ergul E, Ozgun YM, Kiyak G, Barit Ozgun G, Korukluoglu B, Kusdemir A. Does low molecular weight heparin impair anastomotic wound healing? J Gastrointest Surg. 2009;13(4):798-803.
14. Scharf Y, Hershkoviz R. Enoxaparin induced skin necrosis. Harefuah. 2003;142(11):742-3, 807
15. Oliveira PG, Sousa JB, Reys LG, Magalhães AV, Rabelo Fde S, Muniz KC. Effects of enoxaparin on the healing of abdominal wall in rats: study on breaking strength and histopathology. Acta Cir Bras. 2006;21(4):247-51.
16. Hardy RG, Williams L, Dixon JM. Use of enoxaparin results in more haemorrhagic complications after breast surgery than unfractionated heparin. Br J Surg. 2008;95(7):834-6.
17. Laplante AF, Germain L, Augner FA, Moulin V. Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. Faseb J. 2001;15(13):2377-89.
18. Wang Z, Jiang J. Wound healing research in the new century. Chin Med J (Engl). 2000;113(4):383-4.
19. Weimann BJ, Hermann D. Studies on wound healing effects of calcium D-pantothenate on migration, proliferation and protein synthesis of human dermal fibroblasts in culture. Int J Vitam Nutr Res. 1999;69(2):113-9.
20. Iverson DA, Daily WA, Hartzer M, Chapman C. The effect of low molecular weight heparin on the mitogenicity of intraocular fluid from patients with proliferative ratinopathies. Invest Ophthalmol Vis Sci. 1991;32(Suppl):819.
21. Khorana AA, Sahni A, Altland OD, Francis CW. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight. Arterioscler Thromb Vasc Biol. 2003;23(11):2110-5.
22. Hanke H, Oberhoff M, Hanke S, Hassenstein S, Kamenz J, Schmid KM, Betz E, Karsch KR. Inhibition of cellular proliferation after experimental balloon angioplasty by low molecular weight heparin. Circulation. 1992;85(4):1548-56.
23. Zhang F, Lei MP, Oswald TM. The effect of vascular endothelial growth factor on the healing of ischemic skin wounds. Br J Plast Surg. 2003;56(4):334-41.